![John Watts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Watts
Direktor/Vorstandsmitglied bei CDx Diagnostics, Inc.
Profil
John Watts currently works at CDx Diagnostics, Inc., as Director and CDx Medical Holdings, Inc., as Director.
Aktive Positionen von John Watts
Unternehmen | Position | Beginn |
---|---|---|
CDx Diagnostics, Inc.
![]() CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Direktor/Vorstandsmitglied | - |
CDx Medical Holdings, Inc.
![]() CDx Medical Holdings, Inc. Medical/Nursing ServicesHealth Services CDx Medical Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Suffern, NY. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
CDx Diagnostics, Inc.
![]() CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Health Technology |
CDx Medical Holdings, Inc.
![]() CDx Medical Holdings, Inc. Medical/Nursing ServicesHealth Services CDx Medical Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Suffern, NY. | Health Services |